Abstract Submission for Invited Speakers
Please refer to the following guidelines and submit your abstracts to the submission page by clicking the "Abstract Submission" button located at the bottom of this page.
Abstract Submission Guidelines
- Author information and abstracts must be submitted in English.
- Abstract title is limited to 150 single-byte characters. (including spaces)
- Abstract is limited to 2,000 single-byte characters. (including spaces)
- A maximum of 20 authors (first author & co-authors) may be registered.
- A maximum of 20 affiliations (including the affiliation of the first author) may be registered.
- Charts or diagrams cannot be included.
Publication in “Annals of Oncology”
Abstracts (oral/ poster) submitted in English for JSMO2023 will be published in ESMO/JSMO Scientific Journal, supplement to "Annals of Oncology" (Elsevier).
If you wish to have your abstract published in "Annals of Oncology," please select "Yes".
However, in case that there is any possibility of duplicate publication or encore publication, please refrain from selecting "Yes".
Disclosure of Conflict of Interest at 2023 the Japanese Society of Medical Oncology Annual Meeting
The presenter (the first author) and the principal investigator must disclose the name of any company or for-profit organization related to medicine they have a relationship with, defined as follows: in the following items (3) to (9), (11), (12), exceeding separately stipulated criteria, and (1), (2), (10), (13) if met. The subject period is from January 1, 2019 - December 31, 2021.
COI Policy (in revision)
Detailed Enforcement Regulations of COI (in revision)
For oral presentation, please use the slide below as a template to disclose conflict of interest.
For poster presentation, please prepare and print out the slide, and put it at lower right of the poster panel.
| 1 | If your study for this presentation is supported by research funds |
|---|---|
| 2 | If you are or have been an employee of a company and / or a profit-making organization related to medicine |
| 3 | If you have earned > ¥1,000,000 / year as an officer or advisor of a company and/or a profit-making organization related to medicine |
| 4 | If you hold > 5% of the stock of a company and/or a profit-making organization related to medicine, or receive dividends > ¥1,000,000/year |
| 5 | If you have earned > ¥1,000,000/year as a patent fee from a company and / or a profit-making organization related to medicine |
| 6 | If you have earned > ¥500,000/year as a lecture fee from a company and / or a profit-making organization related to medicine |
| 7 | If you have earned > ¥500,000/year as a manuscript fee from a company and / or a profit-making organization related to medicine |
| 8 | If you have received > ¥1,000,000/year as research expenses from a company and / or a profit-making organization related to medicine |
| 9 | If you have received > ¥1,000,000/year as a certain contribution from a company and / or a profit-making organization related to medicine |
| 10 | If you are or have been involved in a certain endowed chair funded by a company and / or a profit-making organization related to medicine |
| 11 | If you have earned > ¥1,000,000/year as a fee for expert comment, judgment or testimony in legal proceedings, or others from a company and / or a profit-making organization related to medicine |
| 12 | If you have received remuneration (travel, gifts, or other in-kind payments not directly related to research) equivalent to > ¥50,000/year from a company and / or a profit-making organization related to medicine |
| 13 | If you are a representative of an organization for clinical study which receives research expenses (donation, contract, others) from a company and/or a profit-making organization related to medicine |
To view the PDF files, you may need, "Adobe Reader " (Download Adobe Reader)
Inquiries regarding COI disclosure
The Secretariat of the Japanese Society of Medical Oncology
E-mail: support[A]jsmo[D]or[D]jp( Please change [A]to @ and [D] to . )
Ethical Principles for Declaring Ethical Matters of your Abstract
In order to review whether your abstract is conformed to the standard of applicable research ethics such as "GCP", "GPSP", "Ethical guidelines on medical research on humans", "Ethical guidelines on research on human genome and gene analysis", etc., JSMO asks you to declare the following items:
The content of your declaration will not affect the acceptance or rejection of your abstract. Please submit to the following:
- Does your study include medical research on human subjects, human material or human data? *Required
- Does your study comply with the Declaration of Helsinki?
- Was your study approved by an institutional review board before starting the research?
Abstract Submission
How to Submit an Abstract
All abstracts must be submitted via web abstract submission system “LaCool”.
Please follow the steps below to register and create your own “My LaCool” account for submission.
- Click “Abstract Submission” button below to create a “My LaCool” account by registering your personal information. To complete your account setting, access via registration URL on the automatic delivery mail sent to your registered email address, set up a password and press “Save” button.
- *
- You will see your registered email address is used as an original log-in ID. The original log-in ID can be changed when you set up a password.
- Once your account is set up, press “Return to Top Page (My LaCool)”.
You can register your abstract from “New Submission of Papers” button. - Submit abstracts that are prepared according to the guidelines shown below and press “Save” to complete the submission.
- After the submission is completed, you will receive an automatic delivery mail sent to the registered email address. If you are unable to receive the automatic delivery mail, please go back to the submission page and make sure the submission is completed by the “Save” button.
- To confirm/modify/delete/add abstracts during the abstract submission period, log in to “My LaCool”, click your abstract registration number (e7XXXX). After making any changes, please make sure to press “Save” button to save added/edited information, or those changes will be discarded.
- *
- Please set up your e-mail account settings to accept emails from “lacool-send-only@convention.co.jp” and “jsmo2023_overseas @convention.co.jp”.
- *
- It is best to avoid using free email services (gmail, hotmail, etc.), if possible.
- *
- To avoid a failure of automatic delivery mail, please make sure that the email address is correct and is not mistyped or misspelt.
- *
- Please make sure to keep your password and log-in ID by yourself. We cannot provide new passwords or ID in any circumstances.
Guideline
We accept abstracts submitted online only through the submission system.
You may enter the submission page from the "Abstract Submission" button at the bottom of this page.
- Author information and abstracts must be submitted in English.
- Abstract title is limited to 150 single-byte characters. (including spaces)
- Abstract is limited to 2,000 single-byte characters. (including spaces)
- A maximum of 20 authors (first author & co-authors) may be registered.
- A maximum of 20 affiliations (including the affiliation of the first author) may be registered.
- Charts or diagrams cannot be included.
- *
- It is recommended that you prepare your abstract text by Word / text file in advance, and then copy it on the registration page.
Inquiries for Abstract Submission
c/o Japan Convention Services, Inc.
Fukuoka Daido Seimei Bldg. 12-33, Nishinakasu, Chuoku,
Fukuoka, 810-0002, Japan
E-mail: jsmo2023_overseas[A]convention[D]co[D]jp( Please change [A]to @ and [D] to . )
